Bioscience

Catapult BioAccel Funds Arizona Early Stage Biotech Company

October 27, 2009

By Flinn Foundation

[Source: Biospace] – Catapult BioAccel, formerly named CatapultBio, has announced the funding of an Arizona-based early stage firm, Kemeta LLC, a company developing a revolutionary product for application in consumer health and medical markets.

For more information: Catapult BioAccel Funds Arizona Early Stage Biotech Company